BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29516977)

  • 1. Clinical efficacy of endovascular radiofrequency ablation in the treatment of portal vein tumor thrombus of primary hepatocellular carcinoma.
    Chen ZW; Lin ZY; Chen YP; Chen J; Chen J
    J Cancer Res Ther; 2018 Jan; 14(1):145-149. PubMed ID: 29516977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous Endovascular Radiofrequency Ablation for Malignant Portal Obstruction: An Initial Clinical Experience.
    Wu TT; Li HC; Zheng F; Ao GK; Lin H; Li WM
    Cardiovasc Intervent Radiol; 2016 Jul; 39(7):994-1000. PubMed ID: 26943811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anlotinib followed by transarterial chemoembolization and radiofrequency ablation is a safe and effective initial treatment for hepatocellular carcinoma patients with portal vein tumor thrombus: A retrospective case series study.
    Wang J; Li X; Wang F; Shi D; Zhang J
    J Cancer Res Ther; 2021 Jul; 17(3):619-624. PubMed ID: 34269290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
    Zhao M; Wang JP; Li W; Huang ZL; Zhang FJ; Fan WJ; Zhang L; Li XS; Pan CC; Wu PH
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1167-72. PubMed ID: 21756768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of portal vein tumor thrombus of hepatocellular carcinoma with percutaneous laser ablation.
    Lu ZH; Shen F; Yan ZL; Li J; Yang JH; Zong M; Shi LH; Wu MC
    J Cancer Res Clin Oncol; 2009 Jun; 135(6):783-9. PubMed ID: 19034515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma invading portal venous system in cirrhosis: long-term results of percutaneous radiofrequency ablation of both the nodule and portal vein tumor thrombus. A case control study.
    Giorgio A; Calisti G; Montesarchio L; Scognamiglio U; Matteucci P; Coppola C; Scarano F; Amendola F; Giorgio V
    Anticancer Res; 2014 Nov; 34(11):6785-90. PubMed ID: 25368292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma with cirrhosis: are patients with neoplastic main portal vein invasion eligible for percutaneous radiofrequency ablation of both the nodule and the portal venous tumor thrombus?
    Giorgio A; Di Sarno A; de Stefano G; Farella N; Scognamiglio U; de Stefano M; Giorgio V
    AJR Am J Roentgenol; 2009 Oct; 193(4):948-54. PubMed ID: 19770315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
    Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical evaluation of percutaneous endovascular radiofrequency ablation for portal vein tumor thrombus: experience in 120 patients.
    Kong YL; Sun JJ; Zhang HY; Xing Y; Wang C; Liu Y; He XJ; Kong LH; Liu CL
    Surg Endosc; 2023 Feb; 37(2):1173-1180. PubMed ID: 36149506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel percutaneous radiofrequency ablation of portal vein tumor thrombus: safety and feasibility.
    Mizandari M; Ao G; Zhang Y; Feng X; Shen Q; Chen M; Lau W; Nicholls J; Jiao L; Habib N
    Cardiovasc Intervent Radiol; 2013 Feb; 36(1):245-8. PubMed ID: 22855240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous radiofrequency ablation of hepatocellular carcinoma in the presence of portal vein thrombosis.
    Neeman Z; Libutti SK; Patti JW; Wood BJ
    Clin Imaging; 2003; 27(6):417-20. PubMed ID: 14585572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endovascular placement of iodine-125 seed strand and stent combined with chemoembolization for treatment of hepatocellular carcinoma with tumor thrombus in main portal vein.
    Luo J; Yan Z; Liu Q; Qu X; Wang J
    J Vasc Interv Radiol; 2011 Apr; 22(4):479-89. PubMed ID: 21463757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced microperfusion due to portal vein thrombosis: Impact on the outcome of percutaneous thermal tumor ablation.
    Pregler B; Beyer LP; Wiesinger I; Haimerl M; Stroszczynski C; Jung EM; Wiggermann P
    Clin Hemorheol Microcirc; 2017; 67(3-4):383-388. PubMed ID: 28885205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
    Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF
    World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth velocity of the portal vein tumor thrombus accelerated by its progression, alpha-fetoprotein level, and liver fibrosis stage in patients with hepatocellular carcinoma.
    Gon H; Kido M; Tanaka M; Kinoshita H; Komatsu S; Tsugawa D; Awazu M; Toyama H; Matsumoto I; Itoh T; Fukumoto T
    Surgery; 2018 Nov; 164(5):1014-1022. PubMed ID: 30093272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein.
    Ye HH; Ye JZ; Xie ZB; Peng YC; Chen J; Ma L; Bai T; Chen JZ; Lu Z; Qin HG; Xiang BD; Li LQ
    World J Gastroenterol; 2016 Apr; 22(13):3632-43. PubMed ID: 27053855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous radiofrequency ablation for early hepatocellular carcinoma: risk factors for survival.
    Kikuchi L; Menezes M; Chagas AL; Tani CM; Alencar RS; Diniz MA; Alves VA; D'Albuquerque LA; Carrilho FJ
    World J Gastroenterol; 2014 Feb; 20(6):1585-93. PubMed ID: 24587635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hepatocellular carcinoma with portal vein tumor thrombus: advances and challenges.
    Jiang JF; Lao YC; Yuan BH; Yin J; Liu X; Chen L; Zhong JH
    Oncotarget; 2017 May; 8(20):33911-33921. PubMed ID: 28430610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of hepatocellular carcinoma with portal vein tumor thrombus:assessment based on clinical and computer tomography characteristics.
    Jia L; Kiryu S; Watadani T; Akai H; Yamashita H; Akahane M; Ohtomo K
    Acta Med Okayama; 2012; 66(2):131-41. PubMed ID: 22525471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.